Drug-resistant bacteria and fungi are evolving at a rapid pace. Within three decades, these “superbugs,” could kill up to 10 million people each year. Working to Fight AMR seeks to combat this public health crisis by stimulating the production of new antimicrobial medicines. Scientists have developed only one truly novel antibiotic since 1984, and just 1% of medicines in development globally address bacterial infections.
Without effective antibiotics, infections like UTIs will become very difficult to treat, and surgeries and cancer treatment will become even riskier. We have time to change this bleak future; we have time to turn American innovation into life-saving cures; you have time to send a message to Washington today.
The economics of this issue are upside down, but there are smart policies in Congress that could catalyze the creation of new antimicrobials.
We need your help.
Action in Congress could accelerate the creation of new antimicrobials. To ensure that Washington, D.C. understands the urgency of this crisis, lawmakers need to hear from you. Use this form to easily send a message to your elected representatives and tell them to help stop the spread of superbugs by passing impactful legislation that encourages private sector investment.
Without effective antimicrobials, we will return to the medical dark ages.
Many companies have stopped investing in antibiotic research.
Diseases know no borders, and we are currently unable to stop the invasion of harmful bacteria.
A decade of work helped limit the spread of dangerous pathogens in medical settings. Overcrowding from Covid care is allowing…Read More
Issue No. 12: The Cost of Inaction on AMR The human cost of drug-resistant superbugs is alarming Right now, 700,000…Read More
Covid-19 offered the general public a quick and devastating lesson on the threat of infectious diseases. But as an infectious disease…Read More
Antimicrobial resistance could 'undermine ... care as we know it,' a leading infectious disease doctor tells TheStreet. Spring was just…Read More